Maple Rock Capital Partners’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134M Buy
2,166,000
+576,900
+36% +$34.8M 2.62% 11
2026
Q1
$92.9M Sell
1,589,100
-66,200
-4% -$3.92M 3.02% 8
2025
Q4
$93.7M Buy
1,655,300
+485,500
+42% +$26.5M 3.1% 9
2025
Q3
$62.1M Sell
1,169,800
-176,600
-13% -$9.59M 2.45% 15
2025
Q2
$63.7M Buy
+1,346,400
New +$59.6M 3.12% 11

Other funds holding BTI

Maple Rock Capital Partners's BTI Position: Q2 2026 in Review

Maple Rock Capital Partners increased its British American Tobacco (BTI) stake by 36% in Q2 2026, buying an estimated $34.8M and bringing the position to 2,166,000 shares worth $134M. The position accounts for 2.62% of the portfolio, ranked #11.

Maple Rock Capital Partners first reported a position in BTI in Q2 2025 and has held it in 5 quarters since. 904 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Maple Rock Capital Partners held 2,166,000 shares of British American Tobacco worth $134M as of Q2 2026.
  • Maple Rock Capital Partners bought 576,900 British American Tobacco shares in Q2 2026, an estimated $34.8M.
  • British American Tobacco made up 2.62% of Maple Rock Capital Partners's portfolio in Q2 2026, its #11 holding.
  • Maple Rock Capital Partners first reported a position in British American Tobacco in Q2 2025 and has held it in 5 quarters since.
  • 904 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Maple Rock Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.